212 related articles for article (PubMed ID: 9249778)
1. Interferon treatment for hepatitis C virus infection in patients on haemodialysis.
Chan TM; Wu PC; Lau JY; Lok AS; Lai CL; Cheng IK
Nephrol Dial Transplant; 1997 Jul; 12(7):1414-9. PubMed ID: 9249778
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and tolerance of interferon-alpha(2b) in the treatment of chronic hepatitis C virus infection in haemodialysis patients. Pre- and post-renal transplantation assessment.
Campistol JM; Esforzado N; Martínez J; Roselló L; Veciana L; Modol J; Casellas J; Pons M; de Las Cuevas X; Piera J; Oliva JA; Costa J; Barrera JM; Bruguera M
Nephrol Dial Transplant; 1999 Nov; 14(11):2704-9. PubMed ID: 10534516
[TBL] [Abstract][Full Text] [Related]
3. Improved sustained response following treatment of chronic hepatitis C by gradual reduction in the interferon dose.
Shiffman ML; Hofmann CM; Luketic VA; Sanyal AJ; Contos MJ; Mills AS
Hepatology; 1996 Jul; 24(1):21-6. PubMed ID: 8707264
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of simple assays for serum concentration of hepatitis C virus RNA and HCV genotype in predicting the response of patients with chronic hepatitis C to interferon alpha 2a therapy.
Suzuki T; Tanaka E; Matsumoto A; Urushihara A; Sodeyama T
J Med Virol; 1995 Jun; 46(2):162-8. PubMed ID: 7636506
[TBL] [Abstract][Full Text] [Related]
5. Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: results of an international randomized controlled trial. Clinical Advisory Group for the Hepatitis C Comparative Study.
Farrell GC; Bacon BR; Goldin RD
Hepatology; 1998 Apr; 27(4):1121-7. PubMed ID: 9537453
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness and tolerance of interferon-alpha 2b in the treatment of chronic hepatitis C in haemodialysis patients.
Pol S; Thiers V; Carnot F; Zins B; Roméo R; Berthelot P; Bréchot C
Nephrol Dial Transplant; 1996; 11 Suppl 4():58-61. PubMed ID: 8918758
[TBL] [Abstract][Full Text] [Related]
7. Biochemical and virological response of chronic hepatitis C after treatment with interferon-alpha for 6 or 12 months: predictors of sustained remission.
Papatheodoridis GV; Katsoulidou A; Touloumi G; Delladetsima JK; Hatzakis A; Tassopoulos NC
Eur J Gastroenterol Hepatol; 1996 May; 8(5):469-75. PubMed ID: 8804876
[TBL] [Abstract][Full Text] [Related]
8. [HCV RNA clearance after treatment with interferon-alpha in chronic hemodialysis patients with or without coinfection by HGV/HGBV-C].
Rostaing L; Izopet J; Moussion F; Alric L; Verdier D; That HT; Duffaut M; Durand D; Puel J; Suc JM
Nephrologie; 1997; 18(7):281-6. PubMed ID: 9496568
[TBL] [Abstract][Full Text] [Related]
9. Changes in serum hepatitis C virus RNA titer and response to interferon therapy in patients with chronic hepatitis C.
Aiyama T; Yoshioka K; Hirofuji H; Kusakabe A; Yamada M; Tanaka K; Kakumu S
Dig Dis Sci; 1994 Oct; 39(10):2244-9. PubMed ID: 7924750
[TBL] [Abstract][Full Text] [Related]
10. Interferon-alpha therapy for individuals with normal serum alanine aminotransferase levels before treatment.
Orito E; Mizokami M; Suzuki K; Ohba KI; Ohno T; Mizuno M; Iijima Y; Saito H; Nemoto A; Nukuta N
J Gastroenterol Hepatol; 1997 Jan; 12(1):58-61. PubMed ID: 9076625
[TBL] [Abstract][Full Text] [Related]
11. Biochemical and virological outcome of patients with chronic hepatitis C treated with interferon alfa-2b for 6 or 12 months: a 4-year follow-up of 211 patients.
Manesis EK; Papaioannou C; Gioustozi A; Kafiri G; Koskinas J; Hadziyannis SJ
Hepatology; 1997 Sep; 26(3):734-9. PubMed ID: 9303505
[TBL] [Abstract][Full Text] [Related]
12. Serum hepatitis C virus RNA level as a predictor of subsequent response to interferon-alpha therapy in Japanese patients with chronic hepatitis C.
Orito E; Mizokami M; Nakano T; Terashima H; Nojiri O; Sakakibara K; Mizuno M; Ogino M; Nakamura M; Matsumoto Y
J Med Virol; 1994 Dec; 44(4):410-4. PubMed ID: 7897373
[TBL] [Abstract][Full Text] [Related]
13. Significance of anti-hepatitis C virus core IgM antibodies in patients with chronic hepatitis C.
Pawlotsky JM; Darthuy F; Rémiré J; Pellet C; Udin L; Stuyver L; Roudot-Thoraval F; Duvoux C; Douvin C; Mallat A
J Med Virol; 1995 Nov; 47(3):285-91. PubMed ID: 8551282
[TBL] [Abstract][Full Text] [Related]
14. Quantification of the initial decline of serum hepatitis C virus RNA and response to interferon alfa.
Zeuzem S; Lee JH; Franke A; Rüster B; Prümmer O; Herrmann G; Roth WK
Hepatology; 1998 Apr; 27(4):1149-56. PubMed ID: 9537457
[TBL] [Abstract][Full Text] [Related]
15. A double-blind controlled trial of recombinant interferon-alpha 2b in haemodialysis patients with chronic hepatitis C virus infection and abnormal aminotransferase levels. Nephrologists' Group for the Study of HCV infection.
Fernández JL; Rendo P; del Pino N; Viola L
J Viral Hepat; 1997 Mar; 4(2):113-9. PubMed ID: 9097267
[TBL] [Abstract][Full Text] [Related]
16. HCV viraemia is more important than genotype as a predictor of response to interferon in Sicily (southern Italy).
Magrin S; Craxi A; Fabiano C; Marino L; Fiorentino G; Lo Iacono O; Volpes R; Di Marco V; Almasio P; Vaccaro A; Urdea MS; Wilber JC; Bonura C; Gianguzza F; Capursi V; Filiberti S; Stuyver L; Pagliaro L
J Hepatol; 1996 Nov; 25(5):583-90. PubMed ID: 8938531
[TBL] [Abstract][Full Text] [Related]
17. Loss of serum HCV RNA at week 4 of interferon-alpha therapy is associated with more favorable long-term response in patients with chronic hepatitis C.
Orito E; Mizokami M; Suzuki K; Ohba K; Ohno T; Mori M; Hayashi K; Kato K; Iino S; Lau JY
J Med Virol; 1995 Jun; 46(2):109-15. PubMed ID: 7636496
[TBL] [Abstract][Full Text] [Related]
18. Comparison of quantitative cDNA-PCR with the branched DNA hybridization assay for monitoring plasma hepatitis C virus RNA levels in haemophilia patients participating in a controlled interferon trial.
Bresters D; Cuypers HT; Reesink HW; Mauser-Bunschoten EP; van den Berg HM; Schaasberg WP; Wilber JC; Urdea MS; Neuwald P; Lelie PN
J Med Virol; 1994 Jul; 43(3):262-8. PubMed ID: 7931188
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of interferon alfa therapy in chronic hepatitis C patients depends primarily on hepatitis C virus RNA level.
Yamada G; Takatani M; Kishi F; Takahashi M; Doi T; Tsuji T; Shin S; Tanno M; Urdea MS; Kolberg JA
Hepatology; 1995 Nov; 22(5):1351-4. PubMed ID: 7590646
[TBL] [Abstract][Full Text] [Related]
20. Rapid clearance of hepatitis C virus RNA in peripheral blood mononuclear cells of patients with clotting disorders and chronic hepatitis C treated with alpha-2b interferon is not a predictor for sustained response to treatment.
Peerlinck K; Willems M; Sheng L; Nevens F; Fevery J; Yap SH; Vermylen J
Br J Haematol; 1994 Apr; 86(4):816-9. PubMed ID: 7918078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
